Cargando…

Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma

BACKGROUND: This study applied a complex bioinformatics analysis to explore the hub regulators and immune network to further elucidate the molecular mechanisms of lung adenocarcinoma (LUAD) immune regulation. METHODS: LUAD immunological microenvironment features and microenvironment-related differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Libao, Xu, Shilei, Huang, Lei, He, Jinyuan, Liu, Gang, Ma, Shaohong, Weng, Yimin, Huang, Shaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797838/
https://www.ncbi.nlm.nih.gov/pubmed/35116596
http://dx.doi.org/10.21037/tcr-20-2275
_version_ 1784641650357698560
author Liu, Libao
Xu, Shilei
Huang, Lei
He, Jinyuan
Liu, Gang
Ma, Shaohong
Weng, Yimin
Huang, Shaohong
author_facet Liu, Libao
Xu, Shilei
Huang, Lei
He, Jinyuan
Liu, Gang
Ma, Shaohong
Weng, Yimin
Huang, Shaohong
author_sort Liu, Libao
collection PubMed
description BACKGROUND: This study applied a complex bioinformatics analysis to explore the hub regulators and immune network to further elucidate the molecular mechanisms of lung adenocarcinoma (LUAD) immune regulation. METHODS: LUAD immunological microenvironment features and microenvironment-related differential expression genes (DEGs) were identified by ESTIMATE algorithm and linear models for microarray analyses (LIMMA), respectively. CIBERSORT and Igraph algorithms were applied to construct the LUAD-related immunocyte infiltration and regulatory network. Kaplan-Meier survival analysis, and univariate and multivariate Cox analysis were used to predict independent risk factors and screen for the hub genes. In addition, hub genes-correlated gene set enrichment analysis (GSEA), tumor mutation burden (TMB), and clinic pathological relation analyses were also performed. RESULTS: Stromal, immune, and microenvironment comprehensive features (ESTIMATE score) were associated with overall survival (OS) in LUAD patients (all, P<0.05). T-cell activation, chemokine activity, and immune effect or dysfunction gene ontology maps were associated with the LUAD immune microenvironment. The immune infiltration cell subtypes mast cells (masT-cells) resting [The Cancer Genome Atlas (TCGA): P=0.01; Gene Expression Omnibus (GEO): P=1.79e−05] and activated T-cells (CD4 memory) (TCGA: P<0.01; GEO: P=8.52e−05) were found to have an important role in the immune cell regulatory network. Finally, ITGAL [univariate hazard ratio (HR) =0.80, 95% confidence interval (CI): 0.69–0.93, P<0.01; multivariate HR =0.59, 95% CI: 0.40–0.86, P=0.01] and KLRB1 (univariate HR =0.78, 95% CI: 0.69–0.89, P<0.01; multivariate HR =0.72, 95% CI: 0.58–0.90, P<0.01) were correlated with the T-cell receptor signaling pathway and anaplastic lymphoma kinase (ALK) fusion (ITGAL: P=0.034; KLRB1: P=0.050), and were considered as candidate biomarkers. A significant relation between KLRB1 expression level and TMB (P=3.6e−05) was identified, while no relation was detected for ITGAL (P=0.11). CONCLUSIONS: The T-cell activation and activated T-cell (CD4 memory) pathways were predominantly involved in LUAD immune microenvironment regulation. The expression levels of ITGAL and KLRB1 were significantly correlated with the T-cell receptor signaling pathway and LUAD TMB, and were independent risk factors for OS.
format Online
Article
Text
id pubmed-8797838
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87978382022-02-02 Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma Liu, Libao Xu, Shilei Huang, Lei He, Jinyuan Liu, Gang Ma, Shaohong Weng, Yimin Huang, Shaohong Transl Cancer Res Original Article BACKGROUND: This study applied a complex bioinformatics analysis to explore the hub regulators and immune network to further elucidate the molecular mechanisms of lung adenocarcinoma (LUAD) immune regulation. METHODS: LUAD immunological microenvironment features and microenvironment-related differential expression genes (DEGs) were identified by ESTIMATE algorithm and linear models for microarray analyses (LIMMA), respectively. CIBERSORT and Igraph algorithms were applied to construct the LUAD-related immunocyte infiltration and regulatory network. Kaplan-Meier survival analysis, and univariate and multivariate Cox analysis were used to predict independent risk factors and screen for the hub genes. In addition, hub genes-correlated gene set enrichment analysis (GSEA), tumor mutation burden (TMB), and clinic pathological relation analyses were also performed. RESULTS: Stromal, immune, and microenvironment comprehensive features (ESTIMATE score) were associated with overall survival (OS) in LUAD patients (all, P<0.05). T-cell activation, chemokine activity, and immune effect or dysfunction gene ontology maps were associated with the LUAD immune microenvironment. The immune infiltration cell subtypes mast cells (masT-cells) resting [The Cancer Genome Atlas (TCGA): P=0.01; Gene Expression Omnibus (GEO): P=1.79e−05] and activated T-cells (CD4 memory) (TCGA: P<0.01; GEO: P=8.52e−05) were found to have an important role in the immune cell regulatory network. Finally, ITGAL [univariate hazard ratio (HR) =0.80, 95% confidence interval (CI): 0.69–0.93, P<0.01; multivariate HR =0.59, 95% CI: 0.40–0.86, P=0.01] and KLRB1 (univariate HR =0.78, 95% CI: 0.69–0.89, P<0.01; multivariate HR =0.72, 95% CI: 0.58–0.90, P<0.01) were correlated with the T-cell receptor signaling pathway and anaplastic lymphoma kinase (ALK) fusion (ITGAL: P=0.034; KLRB1: P=0.050), and were considered as candidate biomarkers. A significant relation between KLRB1 expression level and TMB (P=3.6e−05) was identified, while no relation was detected for ITGAL (P=0.11). CONCLUSIONS: The T-cell activation and activated T-cell (CD4 memory) pathways were predominantly involved in LUAD immune microenvironment regulation. The expression levels of ITGAL and KLRB1 were significantly correlated with the T-cell receptor signaling pathway and LUAD TMB, and were independent risk factors for OS. AME Publishing Company 2021-06 /pmc/articles/PMC8797838/ /pubmed/35116596 http://dx.doi.org/10.21037/tcr-20-2275 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Liu, Libao
Xu, Shilei
Huang, Lei
He, Jinyuan
Liu, Gang
Ma, Shaohong
Weng, Yimin
Huang, Shaohong
Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
title Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
title_full Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
title_fullStr Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
title_full_unstemmed Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
title_short Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
title_sort systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797838/
https://www.ncbi.nlm.nih.gov/pubmed/35116596
http://dx.doi.org/10.21037/tcr-20-2275
work_keys_str_mv AT liulibao systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma
AT xushilei systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma
AT huanglei systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma
AT hejinyuan systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma
AT liugang systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma
AT mashaohong systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma
AT wengyimin systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma
AT huangshaohong systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma